1. Home
  2. THR vs GERN Comparison

THR vs GERN Comparison

Compare THR & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THR
  • GERN
  • Stock Information
  • Founded
  • THR 1954
  • GERN 1990
  • Country
  • THR United States
  • GERN United States
  • Employees
  • THR N/A
  • GERN N/A
  • Industry
  • THR Industrial Machinery/Components
  • GERN Biotechnology: Pharmaceutical Preparations
  • Sector
  • THR Energy
  • GERN Health Care
  • Exchange
  • THR Nasdaq
  • GERN Nasdaq
  • Market Cap
  • THR 887.4M
  • GERN 853.5M
  • IPO Year
  • THR 2011
  • GERN 1996
  • Fundamental
  • Price
  • THR $25.94
  • GERN $1.57
  • Analyst Decision
  • THR Strong Buy
  • GERN Buy
  • Analyst Count
  • THR 1
  • GERN 9
  • Target Price
  • THR $38.00
  • GERN $5.13
  • AVG Volume (30 Days)
  • THR 188.0K
  • GERN 13.0M
  • Earning Date
  • THR 05-22-2025
  • GERN 05-07-2025
  • Dividend Yield
  • THR N/A
  • GERN N/A
  • EPS Growth
  • THR 3.97
  • GERN N/A
  • EPS
  • THR 1.57
  • GERN N/A
  • Revenue
  • THR $498,207,000.00
  • GERN $116,293,000.00
  • Revenue This Year
  • THR $8.84
  • GERN $160.12
  • Revenue Next Year
  • THR $6.23
  • GERN $55.01
  • P/E Ratio
  • THR $16.52
  • GERN N/A
  • Revenue Growth
  • THR 0.72
  • GERN 22264.04
  • 52 Week Low
  • THR $23.05
  • GERN $1.17
  • 52 Week High
  • THR $35.42
  • GERN $5.34
  • Technical
  • Relative Strength Index (RSI)
  • THR 39.49
  • GERN 51.71
  • Support Level
  • THR $25.58
  • GERN $1.30
  • Resistance Level
  • THR $30.17
  • GERN $1.54
  • Average True Range (ATR)
  • THR 0.92
  • GERN 0.11
  • MACD
  • THR -0.47
  • GERN 0.03
  • Stochastic Oscillator
  • THR 6.99
  • GERN 66.67

About THR Thermon Group Holdings Inc.

Thermon Group Holdings Inc is a United States-based company that provides engineered thermal solutions for process industries. The company's product portfolio comprises electric heat tracing cables, steam tracing components, tubing bundles, and instrument and control products, as well as complementary product lines. It also provides turnkey services and design and engineering services. The company's customers include large engineering, procurement, and construction companies; oil and gas companies; commercial subcontractors; electrical component distributors; and others. The company has a presence, with the United States, Canada, and Europe being its top three markets and contributing the majority of its sales.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: